南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

工程化沙门氏菌负载自身抗原纳米颗粒增强个性化肿瘤免疫治疗

Personalized Bacteria Loaded with Autoantigens for the Enhancement of Tumor Immunotherapy

Chenghu Wu, Wenjuan He, Yue Chen, Jie Cai, Fanjun Zeng, Zidong Lu, Jilong Wang

Journal:Advanced Healthcare Materials

IF:10

DOI:10.1002/adhm.202203026

PMID:36602466

Published:2023-01-05

research field:分子生物学药理学细胞生物学心脏病学呼吸生物学纳米技术结构生物学生物化学

Abstract

Currently, tumor immunotherapy is becoming a new revolution in tumor treatment. Generated from tumor cell lysate (TCL) or irradiated tumor cells, the whole tumor antigen-based vaccines have the possibility to enhance antitumor immune response without survival from immune surveillance in personalized immunotherapy. Here, polydopamine nanoparticles (PDA NPs) after self-polymerization are covalently coated with TCL to form PDA@CL. Engineered Salmonella (EnS) wrapped with PDA@CL (EnS@PDA@CL) is targeted the localization of the tumor site by intravenous administration. EnS@PDA@CL delivered autologous antigen-containing nanoparticles to tumor hypoxia regions through blood circulation. The PDA@CL particles promote the maturation of dendritic cells (DCs), thus eliciting the infiltration of whole tumor antigens specific cytotoxic T lymphocytes, significantly triggering antitumor immunity. The tumor regression in the Panc02 mice confirms the therapeutic potential of EnS@PDA@CL in clinical personalized immunotherapy.

本文使用的Yeasen产品

购物车
客服
转染试用